Drug Type CAR-NK |
Synonyms CD38 CAR Engineered Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (Celularity), PNK CAR38, PNKCAR38 |
Target |
Mechanism CD38 inhibitors(Lymphocyte differentiation antigen CD38 inhibitors), T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Preclinical | - | 13 Nov 2019 | |
Multiple Myeloma | Preclinical | - | 13 Nov 2019 |